UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion

Investigative radiology, 2016-11, Vol.51 (11), p.691-700

Lancelot, Eric

2016

Volltextzugriff (PDF)

Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro

Biomaterials, 2007-03, Vol.28 (9), p.1629-1642

2007

Volltextzugriff (PDF)

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review

Toxicology (Amsterdam), 2008-06, Vol.248 (2), p.77-88

2008

Volltextzugriff (PDF)

Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model

Radiology, 2009-08, Vol.252 (2), p.401-409

2009

Volltextzugriff (PDF)

Anti-Inflammatory Drug Evaluation in ApoE−/− Mice by Ultrasmall Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging

Investigative radiology, 2012-09, Vol.47 (9), p.546-552

2012

Volltextzugriff (PDF)

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.425-432

2008

Volltextzugriff (PDF)

Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update

The Radiologic clinics of North America, 2009-09, Vol.47 (5), p.855-869

2009

Volltextzugriff (PDF)

Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure

Investigative radiology, 2022-10, Vol.57 (10), p.664-673

2022

Volltextzugriff (PDF)

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

Radiology, 2009-05, Vol.251 (2), p.429-438

2009

Volltextzugriff (PDF)

Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe

Arteriosclerosis, thrombosis, and vascular biology, 2010-03, Vol.30 (3), p.403-410

2010

Volltextzugriff (PDF)

Assessment of Age Modulated Vascular Inflammation in ApoE−/− Mice by USPIO-Enhanced Magnetic Resonance Imaging

Investigative radiology, 2010-11, Vol.45 (11), p.702-707

2010

Volltextzugriff (PDF)

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer

Investigative radiology, 2020-01, Vol.55 (1), p.20-24

2020

Volltextzugriff (PDF)

In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms

Investigative radiology, 2010-10, Vol.45 (10), p.662-668

2010

Volltextzugriff (PDF)

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

The Journal of neuroscience, 2000-01, Vol.20 (1), p.1-7

2000

Volltextzugriff (PDF)

Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and Efficacy

Investigative radiology, 2020-09, Vol.55 (9), p.578-588

2020

Volltextzugriff (PDF)

Future of Diagnostic Computed Tomography: An Update on Physicochemical Properties, Safety, and Development of X-ray Contrast Media

Investigative radiology, 2020-09, Vol.55 (9), p.598-600

2020

Volltextzugriff (PDF)

Acute Adverse Events after Gadolinium-based Contrast Agent Administration

Radiology, 2019-11, Vol.293 (2), p.481-482

2019

Volltextzugriff (PDF)

Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte–macrophages: Implications for magnetic resonance imaging

Biomaterials, 2008-06, Vol.29 (17), p.2656-2662

2008

Volltextzugriff (PDF)

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

European radiology, 2013-02, Vol.23 (2), p.307-318

2013

Volltextzugriff (PDF)

Transient Signal Intensity Enhancement in the Amniotic Fluid After Administration of a Macrocyclic Gadolinium Chelate to a Pregnant Woman

Journal of magnetic resonance imaging, 2021-08, Vol.54 (2), p.669-671

2021

Volltextzugriff (PDF)

Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children

Pediatric radiology, 2017-11, Vol.47 (12), p.1692-1693

2017

Volltextzugriff (PDF)

Effects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literature

Acta radiologica (1987), 2016-11, Vol.57 (11), p.1334-1343

2016

Volltextzugriff (PDF)

Immediate Allergic Reactions to Gadolinium-based Contrast Agents

Radiology, 2018-03, Vol.286 (3), p.1094-1095

2018

Volltextzugriff (PDF)

A new macromolecular paramagnetic MR contrast agent binds to activated human platelets

Contrast media and molecular imaging, 2007-07, Vol.2 (4), p.178-188

2007

Volltextzugriff (PDF)

Hepatic Gadolinium Deposition in Pediatric Hematopoietic Stem Cell Transplant Recipients

Radiology, 2016-12, Vol.281 (3), p.982-983

2016

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(59)
Animals
(34)
Humans
(29)
Radiology, Nuclear Medicine & Medical Imaging
(25)
Male
(18)
Biological And Medical Sciences
(17)
Mice
(16)
Life Sciences
(13)
Magnetic Resonance Imaging
(13)
Medical Sciences
(12)
Rats
(12)
Atherosclerosis
(10)
Contrast Media
(10)
Female
(10)
Neurosciences & Neurology
(10)
Disease Models, Animal
(9)
Magnetic Resonance Imaging - Methods
(9)
Neurosciences
(8)
Pharmacology & Pharmacy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion

Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review

Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model

Anti-Inflammatory Drug Evaluation in ApoE−/− Mice by Ultrasmall Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach

Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update

Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure

Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo

Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe

Assessment of Age Modulated Vascular Inflammation in ApoE−/− Mice by USPIO-Enhanced Magnetic Resonance Imaging

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer

In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and Efficacy

Future of Diagnostic Computed Tomography: An Update on Physicochemical Properties, Safety, and Development of X-ray Contrast Media

Acute Adverse Events after Gadolinium-based Contrast Agent Administration

Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte–macrophages: Implications for magnetic resonance imaging

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

Transient Signal Intensity Enhancement in the Amniotic Fluid After Administration of a Macrocyclic Gadolinium Chelate to a Pregnant Woman

Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children

Effects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literature

Immediate Allergic Reactions to Gadolinium-based Contrast Agents

A new macromolecular paramagnetic MR contrast agent binds to activated human platelets

Hepatic Gadolinium Deposition in Pediatric Hematopoietic Stem Cell Transplant Recipients

Suchergebnisse filtern